Vertex Pharmaceuticals Incorporated (VRTX)

Mae Love
December 7, 2017

The score helps determine if a company's stock is valuable or not. Volume is simply the number of shares or contracts that trade over a given period of time, usually a day. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.74% with $251.69 Million sitting short, betting on future declines. It was reported on Dec, 5 by Dimensional Fund Advisors LP raised its holdings in Vertex Pharmaceuticals by 2.1% during the first quarter. Tarbox Family Office Inc owns 0.02% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 243 shares. The Hancock Holding Company holds 137,993 shares with $2.29 million value, up from 63,200 last quarter. Vishay Intertech Nology now has $3.07B valuation.

The stock increased 0.82% or $1.1373 during the last trading session, reaching $139.9273. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned "Buy" rating by Jefferies on Wednesday, October 5. Companhia Siderurgica Nacional analysts gave 0 buy-equivalent recommendations, 0 sells and 1 holds. 231.33 million shares or 0.08% less from 231.51 million shares in 2017Q1 were reported. DA Davidson assumed coverage on shares of Vertex Pharmaceuticals in a report on Friday, September 29th. Oppenheimer Asset owns 14,463 shares or 0.05% of their United States portfolio. Principal Grp Inc Inc accumulated 379,838 shares. According to the latest data, the consensus recommendation for Vertex Pharmaceuticals Incorporated (VRTX) is Outperform. During the same period in the previous year, the firm posted $0.16 earnings per share.

In recent action, Vertex Pharmaceuticals Incorporated (VRTX) has made a move of -7.45% over the past month, which has come on weak relative transaction volume. Bailard Incorporated reported 9,230 shares. Laurion Capital Management L P has 22,582 shares. Los Angeles Mngmt Equity Research invested in 3,612 shares or 0% of the stock. Hap Trading Limited Company stated it has 151,644 shares. One Natl Association invested 0.03% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Therefore 83% are positive. UBS downgraded the stock to "Hold" rating in Wednesday, July 19 report. The firm has "Buy" rating given on Wednesday, September 16 by Nomura. The stock has "Outperform" rating by RBC Capital Markets on Thursday, April 28. Of the analysts surveyed by Reuters that track Vertex Pharmaceuticals Incorporated 5 of them rate its stock a hold. The price to earnings ratio for Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) is 186.616440. Vertex Pharmaceuticals has an average rating of "Buy" and a consensus price target of $173.15. The stock of Owens Corning (NYSE:OC) has "Outperform" rating given on Friday, March 31 by Wedbush.

The price to book ratio or market to book ratio for Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) now stands at 20.373971. This public company's current market capitalization stands at $34.97 billion. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Company trades at a P/E ratio of 4.80, and is less expensive than the average stock in the Biotechnology industry. It markets ORKAMBI (lumacaftor in combination with ivacaftor) for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 2 years of age and older who have the G551D mutation or other specified mutations in their CFTR gene.

Public Service Enterprise Group Incorporated (NYSE:PEG): Financial Health and Analyst Ratings
The stock of Public Service Enterprise Group Incorporated (NYSE: PEG ) earned "Hold" rating by Jefferies on Tuesday, June 20. Barclays Capital maintained Public Service Enterprise Group Incorporated (NYSE:PEG) rating on Thursday, September 22.

Alec Baldwin: 'Grand Jury' Late Night Shows Are Harming "Innocent People"
The actor defended his late show criticism on Megyn Kelly Today Thursday, saying he doesn't want innocent people to get in trouble.

Jeremy Corbyn's Momentum allies face Electoral Commission probe
Whether Momentum submitted a return that "was not a complete statement of payments made in respect of controlled expenditure". Submitted a return that did not include all invoices for payments of more than £200.

Analysts await Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to report earnings on January, 24. During the same period in the prior year, the business posted $0.16 earnings per share. OC's profit will be $112.35M for 21.87 P/E if the $1.01 EPS becomes a reality. Finally, Bank of New York Mellon Corp grew its stake in shares of Vertex Pharmaceuticals by 0.6% in the 3rd quarter.

Among 5 analysts covering Vishay Intertechnology (NYSE:VSH), 0 have Buy rating, 2 Sell and 3 Hold. Owens Corning had 69 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has "Overweight" rating given on Tuesday, August 9 by Barclays Capital. The firm has "Buy" rating given on Tuesday, September 26 by Leerink Swann. Susquehanna maintained it with "Positive" rating and $46 target in Thursday, September 3 report. The rating was maintained by Citigroup with "Sell" on Friday, October 27. Stifel Nicolaus maintained Vishay Intertechnology, Inc. The stock of Owens Corning (NYSE:OC) has "Neutral" rating given on Wednesday, July 6 by Wedbush. The stock has "Hold" rating by Vetr on Monday, August 17. The stock of Vishay Intertechnology, Inc. (NYSE:BX), 15 have Buy rating, 0 Sell and 3 Hold.

The Price to book ratio is the current share price of a company divided by the book value per share. Canal Insurance has 40,000 shares for 1.88% of their portfolio. Continental Resources Inc. (NYSE:CLR) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by

Discuss This Article